3 Patents
- 0 cites
- US123658782025Oncolytic Adenovirus with Enhanced Replication Properties Comprising Modifications in E1A, E3, and E4
Salk Institute For Biological Studies
0 cites - US123310762025Alphavirus-based Replicons for Administration of Biotherapeutics
Janssen Pharmaceuticals, Inc.
0 cites